Sanofi

Q2 2026 13F-HR Holdings

Location
Paris, I0
Holdings as of
6/30/2026
Date filed
7/28/2026
Form type
13F-HR
Num holdings
10
Total value ($000)
$534,042
Net value change ($000)
+198,083 (59.0%)
New positions
2
Sold out positions
1
Turnover %
10.5%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/7/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MGTX 59,159 56.0%
Odyssey Therapeutics Inc. 37,269 NEW
INBX 31,866 40.9%
ANAB 25,094 82.6%
First Tracks Biotherapeutics Inc. 16,537 NEW
MPLT 14,146 76.3%
NVAX 8,807 15.7%
AGMB 6,930 23.7%
QTTB 1,543 98.5%
Top Reduces (Value $000, Stocks/ETFs)
ELDN -2,510 -100.0%
IMRX -758 -5.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type